CL2007002007A1 - Compuestos derivados de benzofuro y benzotienopirimidinas, moduladores del receptor de histamina h4; procedimiento de preparacion; y su uso para tratar trastornos inflamatorios, alergicos, dermatologicos, enfermedades autoinmune, linfaticas y de inmu - Google Patents

Compuestos derivados de benzofuro y benzotienopirimidinas, moduladores del receptor de histamina h4; procedimiento de preparacion; y su uso para tratar trastornos inflamatorios, alergicos, dermatologicos, enfermedades autoinmune, linfaticas y de inmu

Info

Publication number: CL2007002007A1
Authority: CL; Chile
Prior art keywords: benzotienopirimidinas; benzofuro; immu; dermatological; lymphatic
Prior art date: 2006-07-11

Application number

CL200702007A

Other languages

English (en)

Inventor

Frank Curtis Michael P Chavez

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-07-11

Filing date

2007-07-10

Publication date

2008-08-22

2007-07-10 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2008-08-22 Publication of CL2007002007A1 publication Critical patent/CL2007002007A1/es

Links

NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 title 2
230000000172 allergic effect Effects 0.000 title 1
208000010668 atopic eczema Diseases 0.000 title 1
230000001363 autoimmune Effects 0.000 title 1
150000001875 compounds Chemical class 0.000 title 1
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
229960001340 histamine Drugs 0.000 title 1
230000002757 inflammatory effect Effects 0.000 title 1
230000001926 lymphatic effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Immunology (AREA)
Endocrinology (AREA)
Pulmonology (AREA)
Reproductive Health (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Cardiology (AREA)
Hematology (AREA)
Ophthalmology & Optometry (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Gastroenterology & Hepatology (AREA)
Agronomy & Crop Science (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Obesity (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Transplantation (AREA)

CL200702007A 2006-07-11 2007-07-10 Compuestos derivados de benzofuro y benzotienopirimidinas, moduladores del receptor de histamina h4; procedimiento de preparacion; y su uso para tratar trastornos inflamatorios, alergicos, dermatologicos, enfermedades autoinmune, linfaticas y de inmu CL2007002007A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US83019206P	2006-07-11	2006-07-11

Publications (1)

Publication Number	Publication Date
CL2007002007A1 true CL2007002007A1 (es)	2008-08-22

Family

ID=38923848

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL200702007A CL2007002007A1 (es)	2006-07-11	2007-07-10	Compuestos derivados de benzofuro y benzotienopirimidinas, moduladores del receptor de histamina h4; procedimiento de preparacion; y su uso para tratar trastornos inflamatorios, alergicos, dermatologicos, enfermedades autoinmune, linfaticas y de inmu

Country Status (24)

Country	Link
US (2)	US7576092B2 (es)
EP (1)	EP2040549B1 (es)
JP (1)	JP5352458B2 (es)
KR (1)	KR20090028819A (es)
CN (1)	CN101511190A (es)
AR (1)	AR061891A1 (es)
AU (1)	AU2007272956B2 (es)
BR (1)	BRPI0715452A2 (es)
CA (1)	CA2657908A1 (es)
CL (1)	CL2007002007A1 (es)
CO (1)	CO6150182A2 (es)
CR (1)	CR10609A (es)
EA (1)	EA015344B1 (es)
EC (1)	ECSP099061A (es)
ES (1)	ES2441958T3 (es)
IL (1)	IL196448A0 (es)
MX (1)	MX2009000457A (es)
MY (1)	MY145349A (es)
NO (1)	NO20090268L (es)
PE (1)	PE20080520A1 (es)
TW (1)	TW200821315A (es)
UY (1)	UY30479A1 (es)
WO (1)	WO2008008359A2 (es)
ZA (1)	ZA200900959B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL2007752T3 (pl)	2006-03-31	2011-02-28	Janssen Pharmaceutica Nv	Benzoimidazol-2-ilopirymidyny i pirazyny jako modulatory receptora histaminowego H4
CL2008000467A1 (es)	2007-02-14	2008-08-22	Janssen Pharmaceutica Nv	Compuestos derivados de 2-aminopirimidina, moduladores del receptor histamina h4; su procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno inflamatorio seleccionado de alegia, asma
WO2009081222A1 (en) *	2007-12-21	2009-07-02	Glenmark Pharmaceuticals, S.A.	Substituted tricyclic pyridine or pyrimidine vanilloid receptor ligands
MX2010013727A (es) *	2008-06-12	2011-01-14	Janssen Pharmaceutica Nv	Uso de un antagonista h4 de histamina para el tratamiento de adherencias postoperatorias.
US9371311B2 (en)	2008-06-30	2016-06-21	Janssen Pharmaceutica Nv	Benzoimidazol-2-yl pyrimidine derivatives
WO2010064705A1 (ja) *	2008-12-05	2010-06-10	大日本住友製薬株式会社	Ｈ４受容体アンタゴニスト作用を有する新規７位置換ジヒドロピラノピリミジン誘導体
WO2010075270A1 (en)	2008-12-22	2010-07-01	Incyte Corporation	4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
EP2201982A1 (en)	2008-12-24	2010-06-30	INSERM (Institut National de la Santé et de la Recherche Médicale)	Histamine H4 receptor antagonists for the treatment of vestibular disorders
IT1393337B1 (it)	2009-03-06	2012-04-20	Italiana Sint Spa	Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina
TW201035078A (en)	2009-03-20	2010-10-01	Incyte Corp	Substituted heterocyclic compounds
EP2671883A1 (en) *	2012-06-05	2013-12-11	Bioprojet	New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands
HUE039713T2 (hu)	2012-06-08	2019-02-28	Sensorion	H4 receptor inhibitorok tinnitus kezelésére
CN102875558A (zh) *	2012-11-05	2013-01-16	贵州大学	2-氯-4-取代-8-硝基苯并呋喃[3,2-d]嘧啶类化合物及其制备方法和用途
SMT202000084T1 (it)	2013-03-06	2020-03-13	Janssen Pharmaceutica Nv	Modulatori benzoimidazol-2-il pirimidinici del recettore h4 dell'istamina
KR20180100705A (ko) *	2016-01-29	2018-09-11	메이지 세이카 파루마 가부시키가이샤	신규 화합물 및 이의 약학적으로 허용 가능한 염
CA3125625A1 (en) *	2019-01-04	2020-07-09	Bellbrook Labs, Llc	Inhibitors of cgas activity as therapeutic agents
US10778972B1 (en)	2019-02-27	2020-09-15	Google Llc	Adaptive filter intra prediction modes in image/video compression
TWI885039B (zh)	2020-01-13	2025-06-01	美商邊際分析公司	經取代吡唑并嘧啶及其用途
FR3109524B1 (fr) *	2020-04-22	2022-04-08	H4 Orphan Pharma	Utilisation d’un ligand multifonctionnel pour traiter l’œil sec et les dysfonctionnements des glandes de Meibomius et des glandes lacrymales.
US20240174684A1 (en) *	2021-02-11	2024-05-30	Bellbrook Labs, Llc	INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTS
CN116589472B (zh) *	2023-05-22	2024-09-13	郑州大学	一种苯并呋喃[3,2-d]并嘧啶-2-胺类化合物及其制备方法和应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3706747A (en) *	1970-06-05	1972-12-19	Pfizer	Benzothieno(3,2-d)- and benzofuro(3,2-d)pyrimidines
US3755583A (en)	1970-06-05	1973-08-28		Chas0!nhx
US3755586A (en) *	1971-03-25	1973-08-28	Warner Lambert Co	Anti tussive compositions containing piperidine derivatives
US4703053A (en) *	1985-10-28	1987-10-27	Warner-Lambert Company	Benzothiophenes and benzofurans and antiallergic use thereof
JPH06220059A (ja)	1993-01-28	1994-08-09	Tanabe Seiyaku Co Ltd	縮合ピリミジン誘導体及びその製法
US6080745A (en)	1993-09-15	2000-06-27	Merck Sharp & Dohme Limited	Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
DE19647927A1 (de) *	1996-11-20	1998-05-28	Bayer Ag	Verfahren zur Herstellung einer stabilen Troponin I Präparation und dessen Verwendung als Kalibrator in Immunoassays
KR100643419B1 (ko)	1998-03-27	2006-11-10	얀센 파마슈티카 엔.브이.	Ｈｉｖ를 억제하는 피리미딘 유도체
CN1346358A (zh)	1999-03-30	2002-04-24	日本曹达株式会社	噻吩并嘧啶化合物及其盐和制备方法
EP1347762A2 (de)	2000-12-19	2003-10-01	MERCK PATENT GmbH	Pharmazeutische formulierung enthaltend thienopyrimidine und antithrombotica, calcium-antagonisten, prostaglandine oder prostaglandinderivate (2)
US6875781B2 (en) *	2003-04-04	2005-04-05	Cell Therapeutics, Inc.	Pyridines and uses thereof
EP1673354B1 (en)	2003-10-03	2009-04-22	Ortho-McNeil Pharmaceutical, Inc.	Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists
US7291733B2 (en) *	2003-10-10	2007-11-06	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted tricyclic heterocycles and their uses
US20050239806A1 (en)	2004-01-13	2005-10-27	Ambit Biosciences Corporation	Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
AU2005226729B2 (en) *	2004-03-25	2010-01-28	Janssen Pharmaceutica N.V.	Imidazole compounds
EP1812113A1 (en)	2004-11-11	2007-08-01	Argenta Discovery Limited	Pyrimidine compounds as histamine modulators
US20060111416A1 (en)	2004-11-24	2006-05-25	Lane Charlotte A L	Octahydropyrrolo[3,4-C]pyrrole derivatives
EP1767537A1 (en) *	2005-09-21	2007-03-28	Cellzome (UK) Ltd.	Pyrimidine compounds for the treatment of inflammatory disorders
EP1829879A1 (en) *	2006-02-10	2007-09-05	Cellzome (UK) Ltd.	Amino pyrimidine compounds for the treatment of inflammatory disorders
WO2007090853A1 (en)	2006-02-10	2007-08-16	Cellzome (Uk) Ltd.	Enantiomers of amino pyrimidine compounds for the treatment of inflammatory disorders
WO2007090854A1 (en)	2006-02-10	2007-08-16	Cellzome (Uk) Ltd.	Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders
WO2008074445A1 (en)	2006-12-18	2008-06-26	Ucb Pharma, S.A.	Novel tricyclic and heterotricyclic derivatives, processes for preparing them, pharmaceutical compositions thereof
WO2009068512A1 (en)	2007-11-30	2009-06-04	Palau Pharma, S. A.	2 -amino-pyrimidine derivatives as histamine h4 antagonists

2007
- 2007-07-10 KR KR1020097002520A patent/KR20090028819A/ko not_active Withdrawn
- 2007-07-10 ES ES07796782.6T patent/ES2441958T3/es active Active
- 2007-07-10 CL CL200702007A patent/CL2007002007A1/es unknown
- 2007-07-10 CA CA002657908A patent/CA2657908A1/en not_active Abandoned
- 2007-07-10 AU AU2007272956A patent/AU2007272956B2/en not_active Ceased
- 2007-07-10 WO PCT/US2007/015763 patent/WO2008008359A2/en not_active Ceased
- 2007-07-10 US US11/827,354 patent/US7576092B2/en active Active
- 2007-07-10 TW TW096124984A patent/TW200821315A/zh unknown
- 2007-07-10 EP EP07796782.6A patent/EP2040549B1/en active Active
- 2007-07-10 PE PE2007000888A patent/PE20080520A1/es not_active Application Discontinuation
- 2007-07-10 MY MYPI20090109A patent/MY145349A/en unknown
- 2007-07-10 BR BRPI0715452-6A patent/BRPI0715452A2/pt not_active IP Right Cessation
- 2007-07-10 CN CNA2007800333205A patent/CN101511190A/zh active Pending
- 2007-07-10 JP JP2009519500A patent/JP5352458B2/ja not_active Expired - Fee Related
- 2007-07-10 EA EA200970113A patent/EA015344B1/ru not_active IP Right Cessation
- 2007-07-10 MX MX2009000457A patent/MX2009000457A/es unknown
- 2007-07-11 UY UY30479A patent/UY30479A1/es unknown
- 2007-07-11 AR ARP070103087A patent/AR061891A1/es not_active Application Discontinuation
2009
- 2009-01-11 IL IL196448A patent/IL196448A0/en unknown
- 2009-01-12 EC EC2009009061A patent/ECSP099061A/es unknown
- 2009-01-16 NO NO20090268A patent/NO20090268L/no not_active Application Discontinuation
- 2009-01-22 CO CO09005353A patent/CO6150182A2/es unknown
- 2009-02-10 ZA ZA200900959A patent/ZA200900959B/xx unknown
- 2009-02-11 CR CR10609A patent/CR10609A/es not_active Application Discontinuation
- 2009-07-02 US US12/496,932 patent/US8030321B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BRPI0715452A2 (pt)	2013-03-05
AU2007272956A1 (en)	2008-01-17
MY145349A (en)	2012-01-31
EA200970113A1 (ru)	2009-06-30
EP2040549B1 (en)	2013-10-23
JP5352458B2 (ja)	2013-11-27
CR10609A (es)	2009-06-04
US20090325927A1 (en)	2009-12-31
ES2441958T3 (es)	2014-02-07
CA2657908A1 (en)	2008-01-17
NO20090268L (no)	2009-03-06
AU2007272956B2 (en)	2013-05-02
WO2008008359A3 (en)	2008-12-31
JP2009543775A (ja)	2009-12-10
IL196448A0 (en)	2009-11-18
UY30479A1 (es)	2008-01-31
US7576092B2 (en)	2009-08-18
WO2008008359A2 (en)	2008-01-17
CO6150182A2 (es)	2010-04-20
EA015344B1 (ru)	2011-06-30
ECSP099061A (es)	2009-02-27
MX2009000457A (es)	2009-01-27
US8030321B2 (en)	2011-10-04
EP2040549A4 (en)	2010-09-08
PE20080520A1 (es)	2008-06-13
TW200821315A (en)	2008-05-16
ZA200900959B (en)	2010-04-28
KR20090028819A (ko)	2009-03-19
CN101511190A (zh)	2009-08-19
US20080015200A1 (en)	2008-01-17
AR061891A1 (es)	2008-10-01
EP2040549A2 (en)	2009-04-01

Publication	Publication Date	Title
CL2007002007A1 (es)	2008-08-22	Compuestos derivados de benzofuro y benzotienopirimidinas, moduladores del receptor de histamina h4; procedimiento de preparacion; y su uso para tratar trastornos inflamatorios, alergicos, dermatologicos, enfermedades autoinmune, linfaticas y de inmu
ECSP12011965A (es)	2012-07-31	Anticuerpos neutralizadores contra el receptor de prolactina y su uso terapéutico
CY2017039I1 (el)	2018-04-04	Αντισωματα υψηλης συγγενειας στον υποδοχεα της ανθρωπινης ιl-6
CL2008000467A1 (es)	2008-08-22	Compuestos derivados de 2-aminopirimidina, moduladores del receptor histamina h4; su procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno inflamatorio seleccionado de alegia, asma
BRPI1012333A2 (pt)	2016-03-29	atropisômeros de derivados de 2-purinil-3-tolil-quinazolinonas e métodos de uso
UY33132A (es)	2011-07-29	Proteínas solubles para su uso terapéutico
BRPI0807487A2 (pt)	2015-09-01	Uso de antagonistas de il-23 para o tratamento de infecção
BRPI0911563A2 (pt)	2016-07-12	uso de antagonista da progesterona
BRPI0921433A2 (pt)	2017-06-06	uso de anticorpos anti-cs1 para o tratamento de linfomas raros
CY2017021I2 (el)	2025-05-09	Υψηλης συναφειας ανθρωπινα αντισωματα προς pcsk9
BRPI0814768A2 (pt)	2015-03-03	Uso terapêutico de anticorpos de receptores anti-tweak
CL2013000930A1 (es)	2014-03-28	Anticuerpo para interleuquina 17 (il-17); uso de dicho anticuerpo para tratar soriasis usando antagonistas de il-17.
FR2945534B1 (fr)	2012-11-16	DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
BR112012002331A2 (pt)	2019-09-24	composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica
BR112014014763A8 (pt)	2017-07-04	novos conjugados de anticorpo-medicamento (adcs) e uso dos mesmos
BR112013009465A2 (pt)	2016-07-12	compósitos reforçados com fibra, pré-forma axissimétrica continua para uso nos mesmos e respectivos métodos de produção
BRPI0921802A8 (pt)	2018-03-13	uso de um inibidor de fosfatidilinositol-3-cinase (pi3k) e um inibidor de mtor,bem como composição e combinação farmacêuticas os compreendendo.
BRPI1015006A2 (pt)	2019-09-24	uso tópico, periocular, ou intraocular de tocotrienóis para o tratamento de doenças oftálmicas
BR112013005071A2 (pt)	2016-04-26	ligante de cimento, concreto e uso de ligante de cimento
PL1904056T3 (pl)	2009-09-30	Zastosowanie makrolidu do przywracania czucia rogówkowego
BR112013004662A2 (pt)	2016-08-02	agonistas de receptores de neurotrofina e o uso destes como medicamentos
FR2953520B1 (fr)	2011-11-25	Derives de diphenyl-pyrazolopyridines, leur preparation et leur application en therapeutique
BRPI0813456A2 (pt)	2014-12-23	Composto, uso do mesmo, composição farmacêutica, e, métodos para tratar um mamífero sofrendo de um distúrbio e de uma doença
BRPI0913188A2 (pt)	2016-01-12	moduladores de receptores 5-ht3, métodos de fabricação, e uso dos mesmos
CO6852025A2 (es)	2014-01-30	El anticuerpo neutralizador del receptor de prolactina mat3 y su uso terapéutico